These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18670810)
1. Preliminary study on high-level expression of tandem-arranged tachyplesin-encoding gene in Bacillus subtilis Wb800 and its antibacterial activity. Dai JG; Xie HW; Jin G; Wang WG; Zhang Y; Guo Y Mar Biotechnol (NY); 2009; 11(1):109-17. PubMed ID: 18670810 [TBL] [Abstract][Full Text] [Related]
2. Expression of recombinant tachyplesin I in Pichia pastoris. Li H; Ali Z; Liu X; Jiang L; Tang Y; Dai J Protein Expr Purif; 2019 May; 157():50-56. PubMed ID: 30711625 [TBL] [Abstract][Full Text] [Related]
3. Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms. Hong J; Hu J; Ke F Antimicrob Agents Chemother; 2016 Oct; 60(10):6067-75. PubMed ID: 27480861 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis-like death-inducing property of tachyplesin I in Escherichia coli. Kwun MS; Lee DG J Basic Microbiol; 2021 Sep; 61(9):795-807. PubMed ID: 34337763 [TBL] [Abstract][Full Text] [Related]
5. A novel expression vector for the secretion of abaecin in Bacillus subtilis. Li L; Mu L; Wang X; Yu J; Hu R; Li Z Braz J Microbiol; 2017; 48(4):809-814. PubMed ID: 28651889 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry. Hong J; Guan W; Jin G; Zhao H; Jiang X; Dai J Microbiol Res; 2015 Jan; 170():69-77. PubMed ID: 25267486 [TBL] [Abstract][Full Text] [Related]
7. Antiviral function of Tachyplesin I against iridovirus and nodavirus. Xie H; Wei J; Qin Q Fish Shellfish Immunol; 2016 Nov; 58():96-102. PubMed ID: 27633674 [TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptides. Kuzmin DV; Emelianova AA; Kalashnikova MB; Panteleev PV; Balandin SV; Serebrovskaya EO; Belogurova-Ovchinnikova OY; Ovchinnikova TV Chem Biol Drug Des; 2018 Jan; 91(1):294-303. PubMed ID: 28815904 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of antibacterial action of tachyplesins and polyphemusins, a group of antimicrobial peptides isolated from horseshoe crab hemocytes. Ohta M; Ito H; Masuda K; Tanaka S; Arakawa Y; Wacharotayankun R; Kato N Antimicrob Agents Chemother; 1992 Jul; 36(7):1460-5. PubMed ID: 1510441 [TBL] [Abstract][Full Text] [Related]
11. Expression levels of antimicrobial peptide tachyplesin I in transgenic Ornithogalum lines affect the resistance to Pectobacterium infection. Lipsky A; Joshi JR; Carmi N; Yedidia I J Biotechnol; 2016 Nov; 238():22-29. PubMed ID: 27639550 [TBL] [Abstract][Full Text] [Related]
12. Influences of disulfide connectivity on structure and antimicrobial activity of tachyplesin I. Shi J; So LY; Chen F; Liang J; Chow HY; Wong KY; Wan S; Jiang T; Yu R J Pept Sci; 2018 Jun; 24(6):e3087. PubMed ID: 29870123 [TBL] [Abstract][Full Text] [Related]
13. Eukaryotic expression and antimicrobial spectrum determination of the peptide tachyplesin II. Xu F; Meng K; Wang YR; Luo HY; Yang PL; Wu NF; Fan YL; Yao B Protein Expr Purif; 2008 Apr; 58(2):175-83. PubMed ID: 18249136 [TBL] [Abstract][Full Text] [Related]
14. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding. Ramamoorthy A; Thennarasu S; Tan A; Gottipati K; Sreekumar S; Heyl DL; An FY; Shelburne CE Biochemistry; 2006 May; 45(20):6529-40. PubMed ID: 16700563 [TBL] [Abstract][Full Text] [Related]
15. Peptide-mediated leishmaniasis management strategy: Tachyplesin emerges as an effective anti-leishmanial peptide against Leishmania donovani. Kumar V; Chugh A Biochim Biophys Acta Biomembr; 2021 Aug; 1863(8):183629. PubMed ID: 33933430 [TBL] [Abstract][Full Text] [Related]
16. Bactericidal action of tachyplesin I against oral streptococci. Masuda K; Ohta M; Ito M; Ohsuka S; Kaneda T; Kato N Oral Microbiol Immunol; 1994 Apr; 9(2):77-80. PubMed ID: 8008433 [TBL] [Abstract][Full Text] [Related]
17. [Bacteria-selective synergism between the antimicrobial peptides magainin 2 and tachyplesin I: toward cocktail therapy]. Kobayashi S Yakugaku Zasshi; 2002 Nov; 122(11):967-73. PubMed ID: 12440153 [TBL] [Abstract][Full Text] [Related]
18. [Construction of an inducible and efficient expression-secretion shuttle vector of B. subtilis]. Li RF; Zhang TY; Luo JX Wei Sheng Wu Xue Bao; 2006 Oct; 46(5):714-9. PubMed ID: 17172015 [TBL] [Abstract][Full Text] [Related]
19. Membrane aggregation and perturbation induced by antimicrobial peptide of S-thanatin. Wu G; Wu H; Li L; Fan X; Ding J; Li X; Xi T; Shen Z Biochem Biophys Res Commun; 2010 Apr; 395(1):31-5. PubMed ID: 20331979 [TBL] [Abstract][Full Text] [Related]
20. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis. Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]